Glomerulonephritis (GN) is a group of kidney diseases which while relatively rare, represent the second most common cause of end-stage renal disease in Canada. GN appears to be increasing in prevalence and disproportionately affecting younger Canadians. Along with our GN Network and Registry and international collaborators, our research aims to identify risks and address gaps and barriers to best care for GN patients.